Aspiriant LLC’s Northrop Grumman NOC Stock Holding History

Aspiriant LLC’s Portfolio NOC Stock Details NOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.37M	Buy	2,837 +148	+6%	+$79.7K	0.03%	143
2026 Q2	$1.37M	Buy	2,689 +86	+3%	+$49.6K	0.03%	147
2026 Q1	$1.78M	Buy	+2,603	New	+$1.8M	0.05%	120
2024 Q2	–	Sell	-431	Closed	-$206K	–	317
2024 Q1	$206K	Hold	431	–	–	0.01%	306
2023 Q4	$202K	Sell	431 -207	-32%	-$97K	0.01%	299
2023 Q3	$281K	Buy	+638	New	+$280K	0.01%	235
2023 Q1	–	Sell	-435	Closed	-$237K	–	289
2022 Q4	$237K	Buy	+435	New	+$227K	0.01%	241

Other funds holding NOC

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Carnegie Investment Counsel Pepper Pike, Ohio $5.01B AUM 15.78% 1-Year Est. Return

Trinity Street Asset Management London, United Kingdom $1.87B AUM 14.76% 1-Year Est. Return

LVM Capital Management Portage, Michigan $1.2B AUM 32.11% 1-Year Est. Return

Aspiriant LLC's NOC Position: Q3 2026 in Review

Aspiriant LLC increased its Northrop Grumman (NOC) stake by 5.5% in Q3 2026, buying an estimated $79.7K and bringing the position to 2,837 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #143.

Aspiriant LLC first reported a position in NOC in Q4 2022 and has held it in 7 quarters since. The position peaked at $1.78M in Q1 2026. 484 funds tracked by Wall St. Rank hold NOC as of Q3 2026.

Aspiriant LLC held 2,837 shares of Northrop Grumman worth $1.37M as of Q3 2026.
Aspiriant LLC bought 148 Northrop Grumman shares in Q3 2026, an estimated $79.7K.
Northrop Grumman made up 0.03% of Aspiriant LLC's portfolio in Q3 2026, its #143 holding.
Aspiriant LLC first reported a position in Northrop Grumman in Q4 2022 and has held it in 7 quarters since.
Aspiriant LLC's Northrop Grumman position peaked at $1.78M in Q1 2026.
484 funds tracked by Wall St. Rank held Northrop Grumman as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.